The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 22 of the 22 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The Diabetes Prevention Program (DPP) and its Outcomes Study (DPPOS) demonstrated that either intensive lifestyle intervention or metformin could prevent type 2 diabetes in high-risk adults for at least 10 years after randomization. We report the 10-year within-trial cost-effectiveness of the interventions. RESEARCH DESIGN AND METHODS: Data on resource utilization, cost, and quality of life were collected prospectively. Economic analyses were performed from health system and societal perspectives. RESULTS: Over 10 years, the cumulative, undiscounted per capita direct medical costs of the interventions, as implemented during the DPP, were greater for lifestyle ($4,572) than metformin ($2,281) or placebo ($752). The cumulative direct medical costs of care outside the DPP/DPPOS were least for lifestyle ($26,810 lifestyle vs. $27,384 metformin vs. $29,007 placebo). The cumulative, combined total direct medical costs were greatest for lifestyle and least for metformin ($31,382 lifestyle vs. $29,665 metformin vs. $29,759 placebo). The cumulative quality-adjusted life-years (QALYs) accrued over 10 years were greater for lifestyle (6.89) than metformin (6.79) or placebo (6.74). When costs and outcomes were discounted at 3% and adjusted for survival, lifestyle cost $12,878 per QALY, and metformin had slightly lower costs and nearly the same QALYs as placebo. CONCLUSIONS: Over 10 years, from a payer perspective, lifestyle was cost-effective and metformin was marginally cost-saving compared with placebo. Investment in lifestyle and metformin interventions for diabetes prevention in high-risk adults provides good value for the money spent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to potential for type 2 diabetes risk reduction, metformin therapy is also a feasible strategy in real world settings, given its association with cost savings. 15”
From Metformin Prescription Rates for Patients with Prediabetes (2022) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Both DPP-modeled intensive lifestyle interventions and individualized MNT for prediabetes have demonstrated costeffectiveness (17,36)”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Economic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323
Herman, W. H., Hoerger, T. J., Brandle, M., Hicks, K., Sorensen, S., Zhang, P., Hamman, R. F., Ackermann, R. T., Engelgau, M. M., Ratner, R. E., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00007 · Cited by 703
Does Preventive Care Save Money? Health Economics and the Presidential Candidates
Cohen, J. T., Neumann, P. J., & Weinstein, M. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmp0708558 · Cited by 471 · cited 1×
“Unfortunately, fewer than 1 in 5 new interventions in health and medicine are cost-saving compared with usual care (17).”
BackgroundThe Diabetes Prevention Program Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.1.36 · Cited by 358
Self-citationRenjilian, D. A., Perri, M. G., Nezu, A. M., McKelvey, W. F., Shermer, R. L., & Anton, S. D. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.69.4.717 · Cited by 327 · cited 2×
“Studies have shown that group intervention programs can be as effective as individual programs (12,13).”
BackgroundClinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes
Eddy, D. M., Schlessinger, L., & Kahn, R. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-4-200508160-00006 · Cited by 318 · cited 2×
“However, one analysis suggested that lifestyle might be too expensive for health plans or a national program to implement (10).”
Background
Research works printed but not linked: 1
- Gold MR Siegel JE Russell LB Weinstein MC (Eds.). Cost-effectiveness in health and medicine. New York, Oxford University Press, 1996
Cited by
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., Allan, S., Caneo, C., Carney, R., Carvalho, A. F., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30132-4 · Cited by 1,531
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
(2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00291-0 · Cited by 1,029
Vitamin D for the prevention of disease: An Endocrine Society clinical practice guideline
Demay, M. B., Pittas, A. G., Bikle, D. D., Diab, D. L., Kiely, M. E., Lazaretti-Castro, M., Lips, P., Mitchell, D. M., Murad, M. H., Powers, S., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae290 · Cited by 639
Prediabetes and what it means: the epidemiological evidence
Echouffo-Tcheugui, J. B., & Selvin, E. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090419-102644 · Cited by 406
Projection of the future diabetes burden in the United States through 2060
Lin, J., Thompson, T. J., Cheng, Y. J., Zhuo, X., Zhang, P., Gregg, E., & Rolka, D. B. (2018) · Population Health Metrics · doi:10.1186/s12963-018-0166-4 · Cited by 335
Hemmingsen, B., Gimenez-Perez, G., Mauricio, D., Roqué i Figuls, M., Metzendorf, M.-I., & Richter, B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003054.pub4 · Cited by 316
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention
Hostalek, U., Gwilt, M., & Hildemann, S. (2015) · Drugs · doi:10.1007/s40265-015-0416-8 · Cited by 278
New insights into osteoporosis: the bone–fat connection
Kawai, M., de Paula, F. J. A., & Rosen, C. J. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02564.x · Cited by 273
Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis
Glechner, A., Keuchel, L., Affengruber, L., Titscher, V., Sommer, I., Matyas, N., Wagner, G., Kien, C., Klerings, I., & Gartlehner, G. (2018) · Primary Care Diabetes · doi:10.1016/j.pcd.2018.07.003 · Cited by 211
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s003 · Cited by 204
3. Prevention or Delay of Type 2 Diabetes:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s003 · Cited by 200
The Diabetes Prevention Program Outcomes Study Research Group; prepared on behalf of the DPPOS Research Group, Orchard, T. J., Temprosa, M., Barrett‐Connor, E., Fowler, S. E., Goldberg, R. B., Mather, K. J., Marcovina, S. M., Montez, M., Ratner, R. E., et al. (2013) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03750.x · Cited by 214
Hu, S., & Lan, C.-C. E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102211 · Cited by 199
for the Diabetes Prevention Program Research Group, Aroda, V. R., Knowler, W. C., Crandall, J. P., Perreault, L., Edelstein, S. L., Jeffries, S. L., Molitch, M. E., Pi-Sunyer, X., Darwin, C., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4361-9 · Cited by 194
Briggs Early, K., & Stanley, K. (2018) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2017.11.021 · Cited by 203
Knowler (2011) · doi:10.1001/archinternmed.2011.367 · Cited by 194
Knowler, W. C. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_16-1 · Cited by 194
The cost of diabetes care-an elephant in the room
Riddle, M. C., & Herman, W. H. (2018) · Diabetes Care · doi:10.2337/dci18-0012 · Cited by 191
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s003 · Cited by 144
Gruss, S. M., Nhim, K., Gregg, E., Bell, M., Luman, E., & Albright, A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1200-z · Cited by 179
The diabetogenic action of statins — mechanisms and clinical implications
Betteridge, D. J., & Carmena, R. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.194 · Cited by 172
Espeland, M. A., Glick, H. A., Bertoni, A., Brancati, F. L., Bray, G. A., Clark, J. M., Curtis, J. M., Egan, C., Evans, M., Foreyt, J. P., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0093 · Cited by 174
Zhou, X., Siegel, K. R., Ng, B. P., Jawanda, S., Proia, K. K., Zhang, X., Albright, A. L., & Zhang, P. (2020) · Diabetes Care · doi:10.2337/dci20-0018 · Cited by 173
Evolving Trends in the Epidemiology, Risk Factors, and Prevention of Type 2 Diabetes: A Review
Weisman, A., Fazli, G. S., Johns, A., & Booth, G. L. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.03.002 · Cited by 159
Efficient treatment of outliers and class imbalance for diabetes prediction
Nnamoko, N., & Korkontzelos, I. (2020) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2020.101815 · Cited by 189
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s003 · Cited by 132
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s003 · Cited by 144
5. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s005 · Cited by 157
Li, R., Qu, S., Zhang, P., Chattopadhyay, S., Gregg, E. W., Albright, A., Hopkins, D., & Pronk, N. P. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0469 · Cited by 152
Marrero, D. G. (2012) · Springer eBooks · doi:10.1007/978-1-4419-1005-9_1199 · Cited by 163
3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s003 · Cited by 162
Holt, R. I. G., de Groot, M., Lucki, I., Hunter, C. M., Sartorius, N., & Golden, S. H. (2014) · Diabetes Care · doi:10.2337/dc13-2134 · Cited by 150
Polygenic Type 2 Diabetes Prediction at the Limit of Common Variant Detection
Vassy, J. L., Hivert, M.-F., Porneala, B., Dauriz, M., Florez, J. C., Dupuis, J., Siscovick, D. S., Fornage, M., Rasmussen-Torvik, L. J., Bouchard, C., et al. (2014) · Diabetes · doi:10.2337/db13-1663 · Cited by 157
Reach and use of diabetes prevention services in the United States, 2016-2017.
Ali, M. K., McKeever Bullard, K., Imperatore, G., Benoit, S. R., Rolka, D. B., Albright, A. L., & Gregg, E. W. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.3160 · Cited by 153
Natural Nrf2 activators in diabetes
Jiménez‐Osorio, A. S., González-Reyes, S., & Pedraza‐Chaverrí, J. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.07.009 · Cited by 161
Cefalu, W. T., Buse, J. B., Tuomilehto, J., Fleming, G. A., Ferrannini, E., Gerstein, H. C., Bennett, P. H., Ramachandran, A., Raz, I., Rosenstock, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0873 · Cited by 142
Sussman, J. B., Kent, D. M., Nelson, J. P., & Hayward, R. A. (2015) · BMJ · doi:10.1136/bmj.h454 · Cited by 143
Older people’s adherence to community-based group exercise programmes: a multiple-case study
Killingback, C., Tsofliou, F., & Clark, C. (2017) · BMC Public Health · doi:10.1186/s12889-017-4049-6 · Cited by 151
O’Connell, J., & Manson, S. M. (2019) · Diabetes Care · doi:10.2337/dci19-0017 · Cited by 152
Sepah, S. C., Jiang, L., & Peters, A. L. (2014) · The Diabetes Educator · doi:10.1177/0145721714531339 · Cited by 139
Roberts, S., Barry, E., Craig, D., Airoldi, M., Bevan, G., & Greenhalgh, T. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017184 · Cited by 122
Type 2 Diabetes and Indigenous Peoples
Crowshoe, L. L., Dannenbaum, D. A., Green, M., Henderson, R., Hayward, M. N., & Toth, E. L. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.022 · Cited by 148
Screening for Diabetes and Prediabetes
Duan, D., Kengne, A. P., & Echouffo-Tcheugui, J. B. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.002 · Cited by 145
Diabetes Prevention Program Research Group, Nathan, D. M., Knowler, W. C., Edelstein, S., Crandall, J. P., Dabelea, D., Goldberg, R. B., Kahn, S. E., Mather, K. J., Trandafirescu, G., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1970 · Cited by 128
3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s003 · Cited by 124
Farrar, D., Simmonds, M., Griffin, S., Duarte, A., Lawlor, D. A., Sculpher, M., Fairley, L., Golder, S., Tuffnell, D., Bland, M., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20860 · Cited by 117
The Reality of Type 2 Diabetes Prevention
Kahn, R., & Davidson, M. B. (2014) · Diabetes Care · doi:10.2337/dc13-1954 · Cited by 112
Lampe, J. W., Huang, Y., Neuhouser, M. L., Tinker, L. F., Song, X., Schoeller, D. A., Kim, S., Raftery, D., Di, C., Zheng, C., et al. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.144840 · Cited by 115
Ard, J. D., Lewis, K. H., Rothberg, A., Auriemma, A., Coburn, S. L., Cohen, S. S., Loper, J., Matarese, L., Pories, W. J., & Periman, S. (2019) · Obesity · doi:10.1002/oby.22303 · Cited by 106
Alouki, K., Delisle, H., Bermúdez-Tamayo, C., & Johri, M. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2159890 · Cited by 94
The Economic Costs of Diabetes: Is It Time for a New Treatment Paradigm?
Herman, W. H. (2013) · Diabetes Care · doi:10.2337/dc13-0270 · Cited by 90
Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost‐effectiveness analysis
Klebanoff, M. J., Corey, K. E., Chhatwal, J., Kaplan, L. M., Chung, R. T., & Hur, C. (2017) · Hepatology · doi:10.1002/hep.28958 · Cited by 91
Classification and Diagnosis of Diabetes
GENUTH, S. M., Palmer, J. P., & Nathan, D. M. (2018) · Cited by 112
Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Adiposity
Cardenas, A., Hauser, R., Gold, D. R., Kleinman, K. P., Hivert, M.-F., Fleisch, A. F., Lin, P.-I. D., Calafat, A. M., Webster, T. F., Horton, E. S., et al. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.1493 · Cited by 89
Yu, W., Jiang, G., Zhang, Y., Liu, D., Xu, B., & Zhou, J. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb02236k · Cited by 94
Sheiner, E., Kapur, A., Retnakaran, R. R., Hadar, E., Poon, L. C., McIntyre, D. H., Divakar, H., Staff, A. C., Narula, J., Kihara, A., et al. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12926 · Cited by 100
A Review of Technology-Assisted Interventions for Diabetes Prevention
Grock, S., Ku, J.-H., Kim, J., & Moin, T. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0948-2 · Cited by 91
Effectiveness and cost-effectiveness of diabetes prevention among adherent participants.
Herman, W. H., Edelstein, S. L., Ratner, R. E., Montez, M. G., Ackermann, R. T., Orchard, T. J., Foulkes, M. A., Zhang, P., Saudek, C. D., & Brown, M. B. (2013) · PubMed · Cited by 91
The Productivity Burden of Diabetes at a Population Level
Magliano, D. J., Martin, V. J., Owen, A. J., Zomer, E., & Liew, D. (2018) · Diabetes Care · doi:10.2337/dc17-2138 · Cited by 81
Moin, T., Li, J., Duru, O. K., Ettner, S., Turk, N., Keckhafer, A., Ho, S., & Mangione, C. M. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1773 · Cited by 90
Suliman, M., Buckley, A., Al Tikriti, A., Tan, T., le Roux, C. W., Lessan, N., & Barakat, M. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13672 · Cited by 86
Garvey, W. T. (2013) · Endocrine Practice · doi:10.4158/ep13263.ra · Cited by 84
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s003 · Cited by 104
Insulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications
Abdul‐Ghani, M. A., Jayyousi, A., DeFronzo, R. A., Asaad, N., & Suwaidi, J. M. S. A. (2017) · Current Vascular Pharmacology · doi:10.2174/1570161115666171010115119 · Cited by 81
5. Prevention or Delay of Type 2 Diabetes
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc17-s008 · Cited by 89
Herman, W. H. (2015) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-015-0009-1 · Cited by 73
Maniar, K., Moideen, A., Mittal, A., Patil, A., Chakrabarti, A., & Banerjee, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.003 · Cited by 77
Hemmingsen, B., Sonne, D. P., Metzendorf, M.-I., & Richter, B. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012151.pub2 · Cited by 60
Review of Metformin Use for Type 2 Diabetes Prevention
Moin, T., Schmittdiel, J. A., Flory, J. H., Yeh, J., Karter, A. J., Kruge, L. E., Schillinger, D., Mangione, C. M., Herman, W. H., & Walker, E. A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.038 · Cited by 75
4. Prevention or Delay of Type 2 Diabetes
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc16-s007 · Cited by 86
Vitamin D insufficiency and insulin resistance in obese adolescents
Peterson, C. A., Tosh, A. K., & Belenchia, A. M. (2014) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018814547205 · Cited by 86
Nhim, K., Gruss, S. M., Porterfield, D. S., Jacobs, S., Elkins, W., Luman, E. T., Van Aacken, S., Schumacher, P., & Albright, A. (2019) · Implementation Science · doi:10.1186/s13012-019-0928-9 · Cited by 71
1-Hour Venous Plasma Glucose and Incident Prediabetes and Diabetes in Asian Indians
Priya, M., Anjana, R. M., Chiwanga, F. S., Gokulakrishnan, K., Deepa, M., & Mohan, V. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0025 · Cited by 75
Metformin and Type 2 Diabetes Prevention
Aroda, V. R., & Ratner, R. E. (2018) · Diabetes Spectrum · doi:10.2337/ds18-0020 · Cited by 70
Madsen, K. S., Chi, Y., Metzendorf, M.-I., Richter, B., & Hemmingsen, B. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008558.pub2 · Cited by 70
Jiao, F. F., Fung, C. S. C., Wan, E. Y. F., Chan, A. K. C., McGhee, S. M., Kwok, R. L. P., & Lam, C. L. K. (2018) · Diabetes Care · doi:10.2337/dc17-1149 · Cited by 69
Unnikrishnan, R., Shaw, J. E., Chan, J. C. N., Wild, S. H., Peters, A. L., Orrange, S., Roden, M., & Mohan, V. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00635-0 · Cited by 77
Metformin for diabetes prevention: update of the evidence base
Gottwald‐Hostalek, U., & Campbell, I. W. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1955667 · Cited by 81
Lin, P. D., Cárdenas, A., Hauser, R. B., Gold, D. R., Kleinman, K., Hivert, M., Calafat, A. M., Webster, T. F., Horton, E. S., & Oken, E. (2021) · Environment International · doi:10.1016/j.envint.2020.106375 · Cited by 69
Definition of intervention points in prediabetes
Ferrannini, E. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70175-x · Cited by 72
Golden, S. H., Maruthur, N., Mathioudakis, N., Spanakis, E., Rubin, D., Zilbermint, M., & Hill-Briggs, F. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0875-2 · Cited by 63
Digital coaching strategies to facilitate behavioral change in type 2 diabetes: a systematic review
Gershkowitz, B. D., Hillert, C. J., & Crotty, B. H. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa850 · Cited by 67
Smartphone applications to support weight loss: current perspectives
Pellegrini, C., Pfammatter, A., Conroy, D., & Spring, B. (2015) · Advanced Health Care Technologies · doi:10.2147/ahct.s57844 · Cited by 62
Targeting the Consequences of the Metabolic Syndrome in the Diabetes Prevention Program
Goldberg, R. B., & Mather, K. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241893 · Cited by 67
Cost-Effectiveness of Family-Based Group Treatment for Child and Parental Obesity
Epstein, L. H., Paluch, R. A., Wrotniak, B. H., Daniel, T. O., KILANOWSKI, C. K., Wilfley, D. E., & Finkelstein, E. A. (2014) · Childhood Obesity · doi:10.1089/chi.2013.0123 · Cited by 65
Spearman, C. W., Afihene, M., Betiku, O., Bobat, B., Cunha, L., Kassianides, C., Katsidzira, L., Desalegn, H., Ocama, P., Ojo, O., et al. (2021) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(21)00275-2 · Cited by 68
Prevention of Diabetes Mellitus in Patients With Prediabetes
Carris, N. W., Magness, R. R., & Labovitz, A. J. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.10.032 · Cited by 66
The cost‐effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity
Lee, M., Lauren, B. N., Zhan, T., Choi, J., Klebanoff, M., Abu Dayyeh, B., Taveras, E. M., Corey, K., Kaplan, L., & Hur, C. (2020) · Obesity Science & Practice · doi:10.1002/osp4.390 · Cited by 61
Williamson, D. A. (2017) · Obesity · doi:10.1002/oby.21914 · Cited by 56
Odnoletkova, I. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000438 · Cited by 59
Mamtani, M., Kulkarni, H. R., Wong, G., Weir, J. M., Barlow, C. K., Dyer, T. D., Almasy, L. A., Mahaney, M. C., Comuzzie, A. G., Glahn, D. C., et al. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0234-3 · Cited by 63
Spreckley, M., Seidell, J., & Halberstadt, J. (2021) · International Journal of Qualitative Studies on Health and Well-being · doi:10.1080/17482631.2020.1862481 · Cited by 56
Arreola, E. V., Gong, Q., Hanson, R. L., Wang, J., Sandforth, L., He, S., Sandforth, A., Qian, X., Giacca, M., Bornstein, S. R., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00295-5 · Cited by 59
Improving diabetes outcomes through lifestyle change—a randomized controlled trial
Delahanty, L. M., Dalton, K. M., Porneala, B., Chang, Y., Goldman, V. M., Levy, D., Nathan, D. M., & Wexler, D. J. (2015) · Obesity · doi:10.1002/oby.21172 · Cited by 55
Precision nutrition in diabetes: when population-based dietary advice gets personal
Merino, J. (2022) · Diabetologia · doi:10.1007/s00125-022-05721-6 · Cited by 58
Economic Costs Attributable to Diabetes in Each U.S. State
Shrestha, S. S., Honeycutt, A., Yang, W., Zhang, P., Khavjou, O., Poehler, D. C., Neuwahl, S. J., & Hoerger, T. J. (2018) · Diabetes Care · doi:10.2337/dc18-1179 · Cited by 59
Khan, T., Tsipas, S., & Wozniak, G. (2017) · Population Health Management · doi:10.1089/pop.2016.0134 · Cited by 47
Metadata
- Authors
- The Diabetes Prevention Program Research Group
- Affiliations
- University of Michigan (US)
- Corresponding author
- The Diabetes Prevention Program Research Group
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-03-13
- Volume
- 35
- Issue
- 4
- Pages
- 723-730
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3308273
- OpenAlex
- W1896651021
- Cited by
- 436
- References
- 22
- Citations by year
- 2026: 16 · 2025: 19 · 2024: 22 · 2023: 19 · 2022: 19 · 2021: 28 · 2020: 38 · 2019: 42 · 2018: 39 · 2017: 43 · 2016: 38 · 2015: 32 · 2014: 29 · 2013: 31 · 2012: 19
- FWCI
- 84.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK092926, P30DK017047)
- National Center for Research Resources
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes prevention, lifestyle intervention, metformin, cost-effectiveness, Diabetes Prevention Program Outcomes Study, quality-adjusted life years, high-risk adults, direct medical costs, resource utilization (health care), health system perspective, societal perspective
- MeSH terms
- Adult, Combined Modality Therapy, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Prediabetic State, Prognosis, Time Factors, Randomized Controlled Trials as Topic, Treatment Outcome, Risk Reduction Behavior, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.